We conducted a population-based study with medical-record review of breast cancer patients as part of a larger study of an oncology outreach program to improve cancer management for rural patients within their community hospital. This analysis compares the breast cancer care received by the rural population before the oncology outreach program with that of the contiguous urban population. All 1986-87 cases in selected Illinois (United States) counties were identified using the Illinois State Cancer Registry. Data were obtained by hospital record audit and physician survey. Case follow-back was 98 percent complete. Rural cases were evaluated separately when they were diagnosed in an urban facility. State-of-the-art management was defined by the 1986-87 Physician Data Query and included diagnostic evaluation, prognostic evaluation, and stage-specific treatment. A summary variable incorporated whether or not the most appropriate management was offered. Compared with urban cases, rural cases diagnosed in rural hospitals were less likely to have staged tumors and more likely to have node dissections. Rural cases traveling to urban centers were less likely to have limited surgery, hormone therapy, and a biopsy as a first-step surgical procedure, and more likely to have node dissection.
Introduction
Cancer occurs less frequently in rural than urban areas. 1-3 Although most reports have focused on urbanrural dichotomies for all cancers, some have shown an urbanization gradient for site-specific cancers. 1,4,s Breast cancer in Illinois (United States) mirrors this urban-rural difference and suggests that although the breast cancer rates are lower in rural areas, the case fatality of rural women with breast cancer is higher than their urban counterparts.
From 1986 to 1990, the age-adjusted breast-cancer incidence rate (standardized to the 1970 US population and using population counts from the 1990 Census) in rural (11-110 persons per square mile) Illinois counties is the lowest of the three population-density groups, with 89.8 cases per 100,000 population. Incidence in counties with small urban areas (120-490 persons per square mile) is 104.0 cases per 100,000 population, and the highest incidence occurs in all urban counties (604-2,261 persons per square mile, excluding Cook County), with 122.1 cases per 100,000 population. In rural counties, the breast-cancer death rate is 30 percent of the incidence; in counties with small cities, it is 28 percent; and in urban counties, it is less than 25 percent.
We conducted a population-based study with medical record review of breast cancer patients as part of a larger study of an oncology outreach program initiated to improve cancer management for rural patients within their community hospital. This analysis compares the breast cancer care received by the rural population before the oncology outreach program with that of two contiguous counties having small urban centers. If disease management were better in the urban area, then the data would be consistent with the differential case-fatality statistics. We hypothesized that a rural population would have less access to oncology expertise and rapidly changing state-of-the-art breast-cancer management than the urban population. We also hypothesized that rural patients who traveled to urban medical centers for cancer care would receive different care from the urban patients managed in the same medical centers due to travel distance, the numbers of visits required for various therapies, and the difficulties for physicians in managing oncology patients from a distance. This paper compares the pattern of care received among three breast-cancer populations: rural patients diagnosed in rural hospitals; rural patients traveling to urban medical centers; and urban patients diagnosed in urban medical centers.
Materials and methods

Case selection
All female breast-cancer cases (International Classification of Diseases for Oncology [ICD-O] code 174) 6 residing in selected Illinois counties and diagnosed in 1986-87 were identified using the Illinois State Cancer Registry (ISCR). The counties were contiguous and included 10 counties with a population density of less than 100 persons per square mile (henceforth called rural) and two counties with about 210 persons per square mile (urban). Each of the urban counties had one city of approximately 100,000 persons. The area was selected because of the oncology outreach program and this analysis used data from the period before the outreach program was initiated.
Data collection
Incidence data were extracted from the ISCR for all cases in the study area. Abstracters reviewed inpatient and outpatient hospital records and all logs for outpatient surgery, laboratory testing, radiation, and chemotherapy. Case-finding steps were implemented to identify cases not reported to ISCR, although none were found.
After completion of the hospital record audits, and with approval by an Institutional Review Board, all physicians (including the attending physician, medical and radiation oncologists, and surgeon) were con- Tumor stage was defined using the tumor node metastasis (TNM) method) ° PDQ recommends tumor staging for all tumors. 7,8 The abstracter interpreted written documented information to stage the cancer (i.e., reliance was not placed on a specific TNM diagram or specific TNM statements). If any of the TNM stage components could not be determined, a code for unknown stage was assigned.
The first course of treatment included all treatment received in the hospital or physician's office during the first six months of disease. We developed a decision tree (available upon request) to determine whether each tumor received state-of-the-art treatment.
Adjuvant hormone, chemical, and radiation therapies were analyzed as dichotomies, despite the timing, dosage, or specific agent. The extent of surgery was considered only in state-of-the-art determination when surgery was too limited for the stage of disease, or in Stage IV if surgery was greater than a total mastectomy. Nomenclature for surgical procedures was standardized by relying upon the specific anatomical structures removed? ~ Since access to state-of-the-art treatment was the measure of concern, patients refusing treatment were included with patients who received it. Contraindications for treatment were noted if they were documented in the medical record; however, for no patient was all forms of treatment contraindicated.
Women under age 50 were considered premenopausal unless specifically documented in the medical record to the contrary. If they were age 50 or older, they were defined as postmenopausal.
Analysis
Data were analyzed using SAS software. Odds ratios (ORs) were calculated using the urban cases as the referent group? 2 All ORs were considered to be significantly different if the 95 percent confidence interval (CI) excluded 1.0. The rural cases were evaluated separately by whether their disease was diagnosed in a rural hospital (rural/rural group) or whether they traveled to urban centers for diagnosis (rural/urban group). The crude ORs were then age-adjusted and age-and stage-adjusted.
Results
Characteristics of the case population
A total of 781 cases was identified, 23 of whom had a multiple primary breast-cancer and were omitted from the analysis. Thirteen other cases were removed from the study because they were classified as one of the following: originally diagnosed in 1985 (n = 3); prior breast cancer diagnosis (n = 1); male (n --1); not breast cancer (n = 3); or not histologically confirmed (n = 5). In addition, four cases diagnosed and treated in other states had incomplete data and were excluded. Due to the small number (n = 24) of Black cases, their concentration in the urban group, and management differences previously identified in the literature, these also were omitted from the analysis. ~ This resulted in 717 cases for the comparative analysis. Table 1 summarizes the demographic and disease characteristics for each group. The cases were similar for the following variables: marital status; menopausal status; tumor histology; and stage of disease. However, Breast cancer management the rural group had more tumors that were not stageable using information in the medical record. Rural cases were also more likely to be aged 75 and older.
Diagnostic evaluation
The occurrence of diagnostic biopsy as a separate surgical procedure occurred significantly less often for rural patients who traveled to urban centers for their cancer diagnosis than it did for urban patients, as shown in Table 2 . This difference was not confounded by age or stage (OR~st~g~.,d i = 0.2, CI = 0.2-0.4).
Prognostic evaluation
The proportions and crude and adjusted ORs for all prognostic evaluation procedures are provided in Table 3 . Rural patients diagnosed in rural facilities are the least likely to have their tumor staged, even after adjusting for the older age of the rural patients (ORage_aaj = 0.1, CI = 0.1-0.2). Rural patients traveling to the same urban medical centers as the urban patients are also less likely to have their tumor staged, although after age-adjustment, the estimate of the OR is less precise (ORage_a~i = 0.5, CI = 0.2-1.1).
Axillary node dissections occur more frequently in rural patients than in urban patients. Among rural patients diagnosed in rural hospitals, the OR becomes significantly elevated after age and stage adjustment (OR age~tag0-~dj = 2.4, CI = 1.1-5.1). Among rural patients traveling to urban centers, the estimate of the OR also increases after adjusting for stage differences (ORa~o/~,ge_aji=3.4, CI= 1.4-8.1). No differences of clinical significance in obtaining hormone assays were found among the three groups.
Among rural patients without adequate information to assign a stage, the missing TNM component was varied. These results and those for the other two groups are summarized in Table 4 .
Treatment
The proportions and ORs for all treatment procedures and access to state-of-the-art treatment are provided in Table 5 . Rural patients traveling to urban centers were the least likely to have limited surgery (ORago/stage_,d i = 0.3, CI = 0.1-0.7). Only hormone therapy in the rural/urban patients suggested differential adjuvant-therapy recommendations among the three groups. Age and stage adjustment also did not cause major modifications in the estimates of these ORs.
Access to state-of-the-art treatment differed among the three groups. The proportions reported in Table 5 exclude patients where state-of-the-art treatment access could not be determined due to missing docu- 
mentation of the outcomes of related management procedures. Nodal status, hormone assay results, stage of disease, and other procedures must be known to ascertain correctly whether treatment was appropriate, or state-of-the-art. If these unknown cases are included in the denominator, the trend for the three groups receiving state-of-the-art therapy remains unchanged. Rural patients diagnosed in rural hospitals were less likely to have access to state-of-the-art treatment after adjusting for age (OR,gelid j = 0.6, CI = 0.4-0.9). How-
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Discussion
Recommendations for state-of-the-art treatment rely on appropriate diagnostic and prognostic evaluation of the disease including bilateral mammography, biopsy, axillary node dissection, hormone assays, and staging of the tumor. Basic health services can be unavailable and difficult to access for rural inhabitants. Specialized disease management, such as the expertise required for cancer care, is particularly cumbersome for rural health providers who tend to be generalists, responsible for a broad range of illnesses and morbidity conditions. They have minimal, if any, access to tumor conferences, continuing education programs, and oncology consultation. The data from this study demonstrate urban-rural differences in tumor staging. Although this finding is consistent with that reported by Lift and colleagues, TM the proportion of unstaged breast cancer in our rural population was much higher (31 percent) compared with White rural women in Georgia (7.1 percent). Unstaged cases also made up a larger proportion of our urban cases (five percent) compared with the urban White cases in Georgia (2.5 percent).
The unstaged patients in the rural group did not differ by age, while those in the rural/urban and urban groups were more likely to be over age 75. For none of the patients did the medical record or physician state that treatment was offered for palliative purposes. Neither was staging related to differences in specific treatment or management practices among the three groups.
After age adjustment, rural/rural patients were significantly less likely to have access to state-of-the-art treatment than urban patients. In the analysis adjusting for both age and stage, which included only those patients with a known tumor stage, this difference was not apparent. Urban-rural differences in state-of-theart treatment access therefore may be related strongly to the differential in tumor staging. These data are consistent with the urban-rural gradient in breast-cancer case-fatality rates among the three populations.
The data also suggest that the need to travel to a city for care is associated with some medical procedures. Rural patients who traveled to urban medical centers were less likely to receive limited surgery, a biopsy separate from the definitive surgical procedure, or hormone therapy. However, by receiving more extensive surgery, these rural/urban patients were also more likely to receive axillary node dissection.
We examined referral networks and potential clustering of specific management practices by individual physician, surgeon, hospital of diagnosis, and town or county of patient residence for outliers that might present other explanations for the urban-rural differences. Sixty-one rural physicians were involved in the care of the 147 rural patients (range 1-9 patients/physician); 55 urban physicians for the 119 rural/urban patients (range 1-11 patients/physician); and 166 urban physicians saw the 451 urban patients (range 1-22 patients/physician).
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Cancer Causes and Control. Vol 3. 1992 Four urban physicians saw approximately one-third of the rural/urban patients. Two differences between these four urban physicians and all other urban physicians were noted in the management of the rural/ urban patient. These four physicians were more likely to recommend state-of-the-art treatment than were all other urban physicians (80 percent cf 55 percent, respectively, P < 0.05). Also, these four physicians were significantly less likely to perform a diagnostic biopsy as a separate surgical procedure (10 percent cf38 percent, respectively, P < 0.001). The significant difference in hormone therapy was not explained by differential practice by the four physicians.
Six rural physicians saw one-third of the rural patients. Only two management practices significantly differed from the other rural physicians: axillary node dissection and hormone therapy (P < 0.05 for each). All other breast-cancer management practices were similar.
Itinerant hospital pathologists are common in the rural areas; however, no inconsistencies were identified between surgical and pathologic reports (e.g., a surgical description that nodes were removed with no documentation of the extent of nodal involvement on the pathology report). The breast-cancer management practices described appear to be widespread and we believe they reflect the standard of practice in these communities.
Miller et al r reported that the urban-rural differences in cancer rates could be explained by age, but this was not supported by our data. Others have suggested that differences in medical care access and available technology for diagnosis and treatment may contribute to the urban-rural gradient observed in site-specific cancer rates, 4,~,15 and our data support this premise for several breast-cancer management procedures.
Several potential limitations in the study design need to be mentioned. The referent group was counties with small urban areas, included because 45 percent of the rural patients traveled for diagnosis and treatment to medical centers located within their borders. Although oncology expertise was available in these urban areas, their hospitals were not major cancer centers nor did they have community clinical-oncology programs (CCOP) during the study period. These factors may have minimized the differences among the groups.
In addition, 'the data rely primarily on documentation of all procedures in the medical record or on a physician's self-report of patient care outside the hospital. Incomplete documentation offers an alternative explanation to the data presented.
Finally, the generalizability of the results may be limited to other rural and small urban settings and not reflect patterns of care in large metropolitan areas.
However, in Illinois, approximately one-third of the cases (2,500 each year) are diagnosed in areas similar to the area studied. The findings of this population-based research design can be relevant and insightful to the experience in similar areas.
This study is important for several reasons. It is a population-based design with intensive medical-record review and high case-ascertainment and physician follow-up. The experience of three groups of breast cancer patients treated by community physicians is described. This may be different from studies about patients treated in major cancer centers, clinical trial programs, or even community-hospital oncology programs. 16, 17 We suggest, as others have, that widespread use of state-of-the-art treatment would reduce rates of breast cancer mortality, TM and that differential urban-rural access to state-of-the-art care contributes to the differential urban-rural rates in breast-cancer case fatality. 16 
